VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 43 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $189,000 | +10.5% | 15,125 | 0.0% | 0.02% | +14.3% |
| Q2 2021 | $171,000 | -25.3% | 15,125 | 0.0% | 0.02% | -34.4% |
| Q1 2021 | $229,000 | +31.6% | 15,125 | 0.0% | 0.03% | +23.1% |
| Q4 2020 | $174,000 | +1.2% | 15,125 | -3.2% | 0.03% | -25.7% |
| Q2 2020 | $172,000 | +0.6% | 15,625 | 0.0% | 0.04% | -16.7% |
| Q1 2020 | $171,000 | -23.7% | 15,625 | +10.6% | 0.04% | -30.0% |
| Q4 2019 | $224,000 | +22.4% | 14,125 | +13.9% | 0.06% | +17.6% |
| Q3 2019 | $183,000 | +46.4% | 12,400 | 0.0% | 0.05% | +34.2% |
| Q2 2019 | $125,000 | -6.7% | 12,400 | 0.0% | 0.04% | -24.0% |
| Q1 2019 | $134,000 | +32.7% | 12,400 | 0.0% | 0.05% | +16.3% |
| Q4 2018 | $101,000 | -42.0% | 12,400 | +15.9% | 0.04% | -47.6% |
| Q3 2018 | $174,000 | -17.5% | 10,700 | 0.0% | 0.08% | -22.6% |
| Q2 2018 | $211,000 | – | 10,700 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 256,244 | $3,203,000 | 0.84% |
| Perceptive Advisors | 3,610,412 | $45,130,000 | 0.66% |
| Orbimed Advisors | 1,479,733 | $18,497,000 | 0.20% |
| Fosun International Ltd | 282,408 | $3,530,000 | 0.18% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 728,236 | $9,103,000 | 0.14% |
| SteelPeak Wealth, LLC | 133,161 | $1,665,000 | 0.11% |
| HighVista Strategies LLC | 10,944 | $137,000 | 0.09% |
| Capital Investment Advisory Services, LLC | 15,125 | $189,000 | 0.02% |
| MML INVESTORS SERVICES, LLC | 44,875 | $561,000 | 0.00% |
| BECK MACK & OLIVER LLC | 10,000 | $125,000 | 0.00% |